Topical Advisory Panel for section 'Cancer Drug Development'

Please see the section webpage for more information on this section.

Members

Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
Interests: cancer cell signaling; infectious agents and cancer; cancer drug targeting-natural compounds; redox signaling in cancer development
Special Issues, Collections and Topics in MDPI journals
Department of Pathology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, China
Interests: anti-tumor pharmacology; programmed cell death; non-coding RNA; native compounds
Special Issues, Collections and Topics in MDPI journals
Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM 87131, USA
Interests: colorectal cancer; iron metabolism; hypoxia signaling; drug delivery
Special Issues, Collections and Topics in MDPI journals

Website
Tumor Biology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, USA
Interests: tumor biology; melanoma; skin cancers; photobiology; photochemistry
Special Issues, Collections and Topics in MDPI journals
Cancer Bioinformatic & Biomarker Lab(CBBL)/Fanconi Anemia Signaling Lab(FASL), Department of Quantitative Health Sciences(DQHS)/Cancer Biology Program(CBP), JABSOM/University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 96813, USA
Interests: transcription factors; cancer metabolism; epigenetics; RNA methylation; pathogenic variants; DDR; Fanconi anemia signaling; DNA-binding proteins
Special Issues, Collections and Topics in MDPI journals
Department of Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: medical oncology; cancer; immunology; clinical trials; targeted therapy; cellular therapy
Special Issues, Collections and Topics in MDPI journals
Back to TopTop